These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 17084625

  • 1. Metabolism of DHEA in postmenopausal women following percutaneous administration.
    Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2007 Feb; 103(2):178-88. PubMed ID: 17084625
    [Abstract] [Full Text] [Related]

  • 2. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
    Labrie F, Bélanger A, Labrie C, Candas B, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):57-69. PubMed ID: 17627814
    [Abstract] [Full Text] [Related]

  • 3. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
    Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):1-9. PubMed ID: 18359622
    [Abstract] [Full Text] [Related]

  • 4. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y, Labrie F, Gonthier R, Simard JN, Bergeron D, Martel C, Vaillancourt M, Montesino M, Lavoie L, Archer DF, Balser J, Moyneur E, other participating Members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [Abstract] [Full Text] [Related]

  • 6. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 7. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E, Pistos C, Provatopoulou X, Athanaselis S, Spiliopoulou C, Gounaris A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec 01; 940():24-34. PubMed ID: 24140653
    [Abstract] [Full Text] [Related]

  • 8. Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.
    Ke Y, Gonthier R, Simard JN, Archer D, Lavoie L, Martel C, Vaillancourt M, Labrie F.
    Horm Mol Biol Clin Investig; 2015 Dec 01; 24(3):117-29. PubMed ID: 26509785
    [Abstract] [Full Text] [Related]

  • 9. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.
    Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2006 Jun 01; 99(4-5):182-8. PubMed ID: 16621522
    [Abstract] [Full Text] [Related]

  • 10. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
    Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2013 Nov 01; 138():359-67. PubMed ID: 23954500
    [Abstract] [Full Text] [Related]

  • 11. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
    Labrie F, Martel C, Balser J.
    Menopause; 2011 Jan 01; 18(1):30-43. PubMed ID: 20683211
    [Abstract] [Full Text] [Related]

  • 12. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 13. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 01; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 14. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.
    Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C.
    J Steroid Biochem Mol Biol; 2008 Sep 01; 111(3-5):178-94. PubMed ID: 18598765
    [Abstract] [Full Text] [Related]

  • 15. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C.
    J Clin Endocrinol Metab; 2009 Jun 01; 94(6):2044-51. PubMed ID: 19318446
    [Abstract] [Full Text] [Related]

  • 16. Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
    Oh H, Wild RA, Manson JE, Bea JW, Shadyab AH, Pfeiffer RM, Saquib N, Underland L, Anderson GL, Xu X, Trabert B.
    Cancer Epidemiol Biomarkers Prev; 2021 Nov 01; 30(11):2018-2029. PubMed ID: 34446472
    [Abstract] [Full Text] [Related]

  • 17. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 01; 6(3):177-81. PubMed ID: 9138660
    [Abstract] [Full Text] [Related]

  • 18. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Bérubé R, Bélanger P, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Mar 01; 16(5):897-906. PubMed ID: 19436226
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ, Slater CC, Ramos DE, Azen C, Cherala G, Hakala C, Abraham G, Roy S.
    Menopause; 2009 Mar 01; 16(2):272-8. PubMed ID: 19098687
    [Abstract] [Full Text] [Related]

  • 20. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov 01; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.